register

News & Trends - MedTech & Diagnostics

Molecular diagnostic company launches next gen PCR technology, with focus on respiratory targets

Health Industry Hub | April 11, 2024 |

Diagnostics & MedTech News: An advancement in PCR technology is improving the target output by twofold. Sydney-based SpeeDx’s technology achieves this without the need for specialised equipment, seamlessly integrating with standard qPCR instrumentation in laboratories.

PCR stands as the gold standard for detecting infections, including respiratory illnesses. Yet, existing laboratory solutions often prove costly, sometimes encompassing unnecessary targets, and struggle to cope with high testing volumes. Applying an innovative approach to standard PCR, SpeeDx has developed PlexPlus, a highly multiplexed, scalable technology that is affordable. 

“I love creating new tech and pushing PCR boundaries.” stated A/Professor Alison Todd, co-founder and Chief Technical Officer of SpeeDx. “Our assays powered with PlexPlus can provide two results per channel, and labs will see immediate benefits in doubling their qPCR system’s usual output. We see endless possibilities for PlexPlus application.”

RespiV PlexPlus, the first product to harness this next generation multiplexing technology, simultaneously detects 14 respiratory viral targets in a single well, namely influenza A virus, influenza B virus, severe acute respiratory syndrome coronavirus 2, respiratory syncytial viruses A and B, adenoviruses B and C, human parainfluenza viruses 1, 2, 3 and 4, human metapneumovirus, rhinovirus and human enterovirus.

“The RespiV PlexPlus assay clearly discriminates between rhinovirus and enterovirus,” stated Yin Xu, Research Manager, SpeeDx, “which will please laboratories that have been requesting this for some time.”

The data gathered within each channel, whether at low or high temperature, remains distinct, devoid of any cross talk. This distinction streamlines result analysis for laboratories, eliminating the necessity for algorithms to discern contributions from various targets measured at the same wavelength.

“The launch of RespiV PlexPlus is an exciting development! The ability to identify many targets in a single well can really improve workflow efficiency. This, along with compatibility with a wide range of qPCR systems commonly found in laboratories means that the labs can’t wait to get their hands on it,” says Colin Denver, CEO of SpeeDx.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.